55,000 Shares in Masimo Co. (NASDAQ:MASI) Acquired by Erste Asset Management GmbH

Erste Asset Management GmbH bought a new position in Masimo Co. (NASDAQ:MASI - Free Report) during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 55,000 shares of the medical equipment provider's stock, valued at approximately $7,333,000. Erste Asset Management GmbH owned 0.10% of Masimo as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. NBC Securities Inc. increased its stake in shares of Masimo by 47.1% during the third quarter. NBC Securities Inc. now owns 228 shares of the medical equipment provider's stock valued at $30,000 after buying an additional 73 shares during the period. GAMMA Investing LLC increased its stake in shares of Masimo by 75.0% during the second quarter. GAMMA Investing LLC now owns 259 shares of the medical equipment provider's stock valued at $33,000 after buying an additional 111 shares during the period. Northwestern Mutual Wealth Management Co. increased its stake in shares of Masimo by 133.3% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 350 shares of the medical equipment provider's stock valued at $44,000 after buying an additional 200 shares during the period. HHM Wealth Advisors LLC increased its stake in shares of Masimo by 25.0% during the second quarter. HHM Wealth Advisors LLC now owns 625 shares of the medical equipment provider's stock valued at $79,000 after buying an additional 125 shares during the period. Finally, Lazard Asset Management LLC increased its stake in shares of Masimo by 5,730.0% during the first quarter. Lazard Asset Management LLC now owns 583 shares of the medical equipment provider's stock valued at $85,000 after buying an additional 573 shares during the period. Hedge funds and other institutional investors own 85.96% of the company's stock.

Masimo Stock Performance

MASI stock traded up $0.11 during trading on Monday, hitting $172.65. 112,421 shares of the company traded hands, compared to its average volume of 673,038. The stock's 50-day simple moving average is $149.24 and its 200 day simple moving average is $129.91. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.01 and a quick ratio of 1.11. The company has a market cap of $9.24 billion, a PE ratio of 118.99 and a beta of 0.97. Masimo Co. has a 1 year low of $96.40 and a 1 year high of $178.27.

Masimo (NASDAQ:MASI - Get Free Report) last posted its quarterly earnings data on Tuesday, November 5th. The medical equipment provider reported $0.98 EPS for the quarter, beating analysts' consensus estimates of $0.84 by $0.14. The business had revenue of $504.60 million during the quarter, compared to analysts' expectations of $502.87 million. Masimo had a return on equity of 14.98% and a net margin of 3.85%. The business's revenue was up 5.4% compared to the same quarter last year. During the same period in the previous year, the business earned $0.63 earnings per share. On average, equities analysts expect that Masimo Co. will post 4.03 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on MASI shares. BTIG Research raised their price objective on Masimo from $166.00 to $170.00 and gave the company a "buy" rating in a research report on Monday, October 14th. Piper Sandler raised their price target on Masimo from $165.00 to $180.00 and gave the stock an "overweight" rating in a report on Wednesday, November 6th. Raymond James raised Masimo from a "market perform" rating to an "outperform" rating and set a $170.00 price target for the company in a report on Wednesday, November 6th. Needham & Company LLC reissued a "hold" rating on shares of Masimo in a report on Wednesday, November 6th. Finally, Wells Fargo & Company raised their price target on Masimo from $160.00 to $171.00 and gave the stock an "overweight" rating in a report on Wednesday, November 6th. Three investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $167.00.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.